@ryobal why I posted the content about direct inoculation.Sterility Test Methods
Two distinct methods are used for sterility testing. First is membrane filtration, which is defined in USP <71> as the preferred method, provided the drug product being tested is filterable. This method involves passing a quantity of drug product through two canisters, each housing a filter designed to retain microorganisms. This is followed by a rinse to ensure no drug product remains on the filter, as that can potentially inhibit the growth of microorganisms. The final step is to fill each canister with one of the two media types described below. The second sterility testing method is direct inoculation. This consists of introducing the drug product directly into each of the two growth media using a defined quantity of drug product sample to growth media. The dilution used must be sufficient to overcome any antimicrobial properties present in the drug product being tested.
@moneybaggs@Hardball69 I am not disappointed in the result nor unhappy with the company.
Direct inoculation does not mean getting someone having Natshield putting onto their body. It is just another way of lab testing the virus in a controlled environment. That means a FELINE virus can still be used in this setting which I think that is still sufficient enough to say Natshield is effective. I am a holder of HCT and support the growth of this product. I am not downramping as I said earlier, but just want us to be careful of using FELINE or HUMAN COVID-19 because they are just the same thing.
- Forums
- ASX - By Stock
- HCT
- Holista CollTech joins forces with GICC to develop works first nasal sanitiser
Holista CollTech joins forces with GICC to develop works first nasal sanitiser, page-1763
-
- There are more pages in this discussion • 306 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.691M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 32051 | 2.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 80000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 32051 | 0.024 |
2 | 267390 | 0.023 |
1 | 500000 | 0.021 |
1 | 30000 | 0.019 |
1 | 508000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 80000 | 1 |
0.028 | 49999 | 1 |
0.029 | 78000 | 2 |
0.030 | 12000 | 1 |
0.031 | 100000 | 1 |
Last trade - 16.12pm 14/10/2024 (20 minute delay) ? |
Featured News
HCT (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online